Company: CMND
Filing Date: 2025-06-12
Form Type: POS AM
Source: 0001213900-25-053898
Chunk: 33

Company: Clearmind Medicine Inc.
Filing Date: 2025-06-12
Form: POS AM
Chunk 33
---
 any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective
until 61 days following notice from the holder to us.

Exercise Price. The exercise price per
whole common share purchasable upon exercise of the January 2024 PIPE Warrants is $1.60 per share. The exercise price is subject
to appropriate adjustment in the event of certain share dividends and distributions, share splits, share combinations, reclassifications
or similar events affecting our common shares and also upon any distributions of assets, including cash, stock or other property to our
shareholders.

Subject to certain exemptions outlined in the
January 2024 PIPE Warrants, for the life of the warrant, if we shall sell, enter into an agreement to sell, or grant any option to purchase,
or sell, enter into an agreement to sell, or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale,
grant or any option to purchase or other disposition) any common shares or convertible security, at an effective price per share less
than the exercise price of the January 2024 PIPE Warrants then in effect, or a Dilutive Issuance, the number of common shares issuable
upon exercise of the January 2024 PIPE Warrant shall be proportionally adjusted so that the aggregate exercise price of the January 2024
PIPE Warrants shall remain unchanged.

Share Combination Event Adjustments. If
at any time on or after the date of issuance there occurs any share split, share dividend, share combination recapitalization or other
similar transaction involving our common shares and the lowest daily volume weighted average price during the five consecutive trading
days commencing on the date of such event is less than the exercise price then in effect, then the exercise price shall be reduced to
the lowest daily volume weighted average price during such five day period and the number of warrant shares issuable shall be increased
such that the aggregate exercise price payable thereunder, after taking into account the decrease in the exercise price, shall be equal
to the aggregate exercise price on the date of issuance. Such adjustment may only be made one time.

Transferability. Subject to applicable
laws, the January 2024 PIPE Warrants may be offered for sale, sold, transferred or assigned without our consent.

Exchange Listing. We do not intend to apply
to list the January 2024 PIPE Warrants on any securities exchange or nationally recognized trading system.

Fundamental Transactions.